Financial Perspectives’s Intersect ENT, Inc XENT Stock Holding History

Financial Perspectives’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-309	Closed	-$8.65K	–	700
2022 Q1	$8.65K	Hold	309	–	–	﹤0.01%	480
2021 Q4	$8.44K	Hold	309	–	–	﹤0.01%	459
2021 Q3	$8.4K	Hold	309	–	–	﹤0.01%	464
2021 Q2	$5.28K	Sell	309 -6,143	-95%	-$115K	﹤0.01%	537
2021 Q1	$309K	Buy	6,452 +6,143	+1,988%	+$142K	0.02%	348
2020 Q4	$7.08K	Hold	309	–	–	﹤0.01%	435
2020 Q3	$5.04K	Hold	309	–	–	﹤0.01%	423
2020 Q2	$4.18K	Hold	309	–	–	﹤0.01%	425
2020 Q1	$3.66K	Hold	309	–	–	﹤0.01%	407
2019 Q4	$7.69K	Buy	+309	New	+$6.26K	0.01%	360

Financial Perspectives's XENT Position: Q2 2022 in Review

Financial Perspectives sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 309 shares — an estimated $8.65K sold.

Financial Perspectives first reported a position in XENT in Q4 2019 and held it in 10 quarters. The position peaked at $309K in Q1 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Financial Perspectives reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Financial Perspectives sold 309 Intersect ENT, Inc shares in Q2 2022, an estimated $8.65K.
Financial Perspectives first reported a position in Intersect ENT, Inc in Q4 2019 and held it in 10 quarters.
Financial Perspectives's Intersect ENT, Inc position peaked at $309K in Q1 2021.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Financial Perspectives's 13F filing for Q2 2022, filed 10 Jan 2024.